IAPO Logo High Resolution
HI! from the IAPO (International Alliance of Patients Organisations) Global Patients Conference 2016!

I’m representing Lupus Europe at this amazing conference!   From www.iapo.org.uk  “150 patients’ advocates from 48 countries are meeting in London to discuss how innovation can help achieve universal, patient-centred and sustainable access to healthcare around the world.”

My objective here was to represent Lupus Europe (we are a voting member), and give visibility to lupus.

–> I have been tweeting as lupuseurope (just during this conference, usually it’s Nuria!) using the hashtag #GPC2016 and #lupus, so you can look through the tweets and see some photos and other quotes from the days.

It’s been very rich agenda so far.   Monday we started with what they called a “Speed-up dating” which was a fun meet and greet. We had two minutes to one person and we had to learn about each other. I met 15 people/groups in 30 mins! I think it’s a great idea to break the ice! 

Then we had the AGM where we heard old business, financials and elected five (!) new board members.

We heard from Jolanta Bilinska (Governing Board Chair) about IAPOs objectives, and Kahwaldip Sehmi, IAPO CEO, about his road to IAPO (he had such good care with his illness that he wanted to make sure everyone could have the same!)
They listed IAPO’s goals as:
Help patients’ organizations to be as effective as possible
Be the leading patients voice on health issues
Empower the global patient movement

They talked about how the UK Charity laws have changed, there are new ways of presenting budgets, and so that took time to adapt.

Keynote speaker: Nicolas Sireau gave a very inspiring speech, about Fundamental Diseases (he has two children with Black Bone disease, an ultra rare disease) It’s on Ted Talk so you can see what he has to say about why it’s so important to study rare diseases: https://www.youtube.com/watch?v=B4UnVlU5hAY

We had a talk from Professor Peter Boyle on the challenge of rising global cancer rates, particularity in lower and middle-class income countries.  He said we had to consider the patients, giving many memorable quotes, such as “statistics are patients with the tears wiped away.”

Then we had Workshops.  I was part of the workshop, “Building effective and innovative networks and campaigns for greater impact.” and presented the Patient Panel work on Adherence to Treatment done by Alain, Bernadette, Davide and Jeanette (among others) in 2014.  The presentation was really well received and so many people were impressed by the work done (well done team!!)

Penny Cowan, American Chronic Pain organisation, gave a really impressive talk about new tools they have invented and are trying to get passed to talk to doctors about pain.  I am sure we could do an excellent adaptation of one for lupus!  They are all available for download from https://theacpa.org/Communication-Tools

There was also an interesting talk from Mattias Wienold, European Aids Treatment Group, and summaries of the other workshops.  All talked about how we need to focus on the patients and the patients need to have endless persistence to get the results they want!

The presentation brought several people to come to talk to me about our lupus work.

End of Day one on Saturday evening – I’ll write about today’s meeting and some of the interesting people I met later or tomorrow.
Thinking of your all!
Anne

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

We are very proud to share that LupusGPT has now been published in The Lancet Rheumatology, one of the world’s leading medical journals in rheumatology.

For us, this is not only about a publication. It is about what LupusGPT stands for.

LupusGPT is free. It is patient-led. And it was built to help people living with lupus find reliable, accessible information in almost any language.

It began with a simple but important question: what could become possible if patients, clinicians, and digital experts truly worked together from the start?

That question was first opened up in a fishbowl discussion at the European Lupus Meeting 2024 on how the lupus community could get the best, but not the worst, out of AI. From there, LupusGPT was shaped through the care, intelligence, and effort of many people: volunteers, patient testers, clinicians testing across languages, people who gave feedback, and people already helping us share it with patients in clinics, organisations, and communities.

This publication matters because it shows that patient-led innovation belongs in the scientific world too. It shows that when patient voice is not added at the end, but built in from the start, something real can grow.

A heartfelt thank you to all authors: Zoe Karakikla-Mitsakou, Alain Cornet, Jeanette Andersen, Sarah Dyball, Cristiana Sieiro Santos, Daniel Guimarães de Oliveira, and Laurent Arnaud. Special thanks also to Daniel Guimarães de Oliveira for the thought, care, and belief he brought to this work, and to Professor Laurent Arnaud for his outstanding support, steadiness, and guidance.

And above all, thank you to everyone in the Lupus Europe community who keeps showing us why this matters.

LupusGPT. Free. Multilingual. Patient-led. And now part of the scientific record.

doi.org/10.1016/S2665-9913(25)00370-4

Read it for free now! You only need to register (registration is completely free and takes 1')
... See MoreSee Less

We are very proud to

🚨 Today is #WORDDAY2026! Which stands for WOrld Young Rheumatic Disease Day.

🌍 Through this global event, we can spread the word that children and young people get rheumatic diseases like lupus, too.

‼️ It is estimated that around 15-20% of #lupus patients are children, although it is rare that a child develops lupus before 5 years of age.

As with adult patients, the cause of lupus remains unknown, and there is a great choice of treatments to keep the disease under control.

🔴 On average, it takes nearly 6 years for people with lupus to be diagnosed. This delay in diagnosis, and therefore in treatment, can have an impact on the prognosis and quality of life of patients; this includes kids.

😰 The moment your child gets a diagnosis might be overwhelming for you. This feeling of overwhelm can and does go away with time and with access to the right information.

👉 Remember: it is impossible to learn everything about #lupus overnight! Your child's doctor is the best source of information.

Apart from pharmacological treatment, other non-pharmacological measures can also help in lupus management.

📷 Take a look at the images we are sharing today to learn about these non-pharmacological measures and share them with your community to help us raise awareness.

🐺 Lupus can seem scary at first. Remember that you are not alone and that you are going to do a great job!

Turn to your lupus association for support.

🤗 There are many organisations across Europe that can help you and your child cope with the disease.

More information on #SLE in children at #Lupus100: f.mtr.cool/oklkpqamyu

For more information on WORD Day, you can visit World Young Rheumatic Diseases Day - WORD Day
... See MoreSee Less

Image attachment
Image attachment
Image attachment
Image attachment
Image attachment

🔴 Tomorrow is #WORDDAY2026!

🦋 And we will be sharing tips and information on how #lupus can affect children.

Help us raise awareness, which is key for an early diagnosis & a quick referral to a specialised paediatric rheumatologist.

Share our posts and follow the World Young Rheumatic Diseases Day - WORD Day campaign.

More information on lupus in children at #Lupus100 (19 languages):

f.mtr.cool/hnfukbkwdf
... See MoreSee Less

🔴 Tomorrow is #WO

Watch this Lupus Europe Webinar on the European Lupus Meeting (ELM) 2026, As Viewed by Lupus Europe's PAN Members & Volunteers!

... See MoreSee Less

0 CommentsComment on Facebook

LUPUS EUROPE Uniting people with Lupus throughout Europe
Send